Laboratory Medicine Program

Multiple Endocrine Neoplasis, Type I (MEN1, CDKN1B)

Clinical Decription:
Multiple endocrine neoplasia, Type I (MEN1) is a rare hereditary condition that is associated with varying combinations of endocrine and non-endocrine tumours that include, but are not limited to parathyroid tumours, pituitary tumours, well-differentiated tumours of the gastro-entero-pancreatic tract, cardinoid tumours and adrenocortical tumours. Individuals with a personal and/or family history of features suggestive of MEN1 may be eligible for genetic testing. Please consult the Cancer Care Ontario document outlining eligibility for genetic testing for hereditary cancer (https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/70161) and/or contact the lab for additional information. Note: This is a blood test for individuals with clinical features and/or a family history of MEN1. It is not a tumour test for somatic gene variants that provide diagnostic, prognostic or therapeutic information.

Method: Next-Generation Sequencing (NGS)

Component Tests Used: n/a

Reference Ranges Used:
Reference ranges for this test are not available online. However, they are included in all test results. For more information, please call us.

Specimen Type: peripheral blood (EDTA)
Volume: 5 mL (minimum: 2 mL)

Shipping: room temperature or 4C

Special Instructions: See requisitions for the full list of available testing and special instructions.

Testing Schedule(s): Please call

Turnaround Time: None

For more information, call 416.340.5227 or 1.866.865.5227